LEAH Labs
https://www.leahlabs.comLiving therapies for pets first, and their people next
LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective "full stack" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.
Total Open and Closed Positions
Total open positions, and positions newly closed since the previous update
Department Headcount Over Time
Open positions per department · top 6 at any point in the window
Newly Opened and Closed Positions
Position Churn Rate
Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels
Time-to-Fill Distribution
Days from open to close · closed positions only
Salary Trend Over Time
Monthly median base salary · USD · annualized · p25/p75 dashed
Salary Range by Department
Employment Type
Technical vs. Non-technical
Open positions · by department
Top Roles by Department
Seniority Mix
Derived from job title keywords
Equity Range by Department
Top Skills
Top Tech Stacks
Skills Trend
Change in share of postings · recent 3 months vs. prior 3 months
Tech Stack Evolution
Positions opened per month · top 5 technologies